Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Alexion Pharm Inc (ALXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,038,916
  • Shares Outstanding, K 223,410
  • Annual Sales, $ 3,084 M
  • Annual Income, $ 399,000 K
  • 36-Month Beta 1.22
  • Price/Sales 7.83
  • Price/Cash Flow 17.99
  • Price/Book 2.70

Price Performance

See More
Period Period Low Period High Performance
1-Month
107.07 +0.50%
on 11/22/17
142.24 -24.35%
on 10/24/17
-31.42 (-22.60%)
since 10/20/17
3-Month
107.07 +0.50%
on 11/22/17
149.34 -27.95%
on 09/05/17
-30.60 (-22.14%)
since 08/22/17
52-Week
96.18 +11.87%
on 05/26/17
149.34 -27.95%
on 09/05/17
-9.42 (-8.05%)
since 11/22/16

Most Recent Stories

More News
Biotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3

After rising 15.4% in the first nine months of the year, the Medical-Biotech /Genetics industry has declined 13.4% so far in the fourth quarter.

CELG : 105.16 (+0.63%)
VRTX : 147.04 (+1.33%)
ABBV : 94.47 (-0.22%)
GILD : 72.82 (+0.43%)
AMGN : 169.96 (+0.07%)
ALXN : 107.60 (-0.42%)
BIIB : 309.80 (+0.24%)
Achillion (ACHN) Shares Down as J&J Announces Stake Sale

Achillion's (ACHN) shares fell following the announcement that J&J will sell its complete stake in the company.

SCMP : 10.40 (+0.48%)
ACHN : 3.36 (-2.04%)
JNJ : 137.29 (-0.76%)
ALXN : 107.60 (-0.42%)
Alexion Employees Volunteer Together to Enhance Their Local Communities during Second Annual Global Day of Service

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced that more than 1,300 employees are rallying together in support of community service initiatives focused on health, wellness, and education...

ALXN : 107.60 (-0.42%)
Alexion Appoints Francois Nader, M.D. to its Board of Directors

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Francois Nader, M.D., has been appointed to the Company's Board of Directors. Dr. Nader is an accomplished leader in the biopharmaceutical...

XLRN : 36.49 (-1.11%)
ALXN : 107.60 (-0.42%)
Tech Tumbles and Oil Boils

Tech Tumbles and Oil Boils

MTOR : 24.03 (-0.29%)
PAYC : 84.78 (-0.42%)
ALXN : 107.60 (-0.42%)
Investor Expectations to Drive Momentum within Carrizo, Coeur, Alexion, Ultra Clean, Alaska Air, and CA - Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Carrizo Oil & Gas, Inc. (NASDAQ:CRZO),...

ALK : 65.58 (-0.92%)
CDE : 7.67 (+0.66%)
UCTT : 24.28 (-7.29%)
CRZO : 20.16 (+7.23%)
CA : 32.45 (-0.40%)
ALXN : 107.60 (-0.42%)
Featured Company News - Japanese Patent Office Issued New Patent to Alexion Pharma's Soliris; Extending Patent Protection into 2027

Research Desk Line-up: Bio-Techne Post Earnings Coverage

TECH : 132.43 (+0.23%)
ALXN : 107.60 (-0.42%)
Alexion Receives New Japanese Patent for Soliris(R) (eculizumab), Extending Patent Protection Into 2027 and Strengthening Global Patent Portfolio

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) announced today that the Japanese Patent Office (JPO) has issued patent No. 6224059, directed to the composition of matter of eculizumab (Soliris(R))...

ALXN : 107.60 (-0.42%)
Achillion (ACHN) Q3 Loss Narrows, Pipeline Expansion in Focus

Achillion Pharmaceuticals' (ACHN) third-quarter loss was narrower than estimates. The company is focusing on expanding its key pipeline candidate in several indications.

ACHN : 3.36 (-2.04%)
JNJ : 137.29 (-0.76%)
EXEL : 26.13 (+0.31%)
ALXN : 107.60 (-0.42%)
New Interim Data Presented at NASPGHAN 2017 Meeting Show Survival Beyond 1 Year of Age in Infants with LAL-D Treated with Kanuma(R) (sebelipase alfa)

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) announced today that new interim data show that 80% of infants (8 out of 10) with rapidly progressive lysosomal acid lipase deficiency (LAL-D)...

ALXN : 107.60 (-0.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company's lead product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system...

See More

Key Turning Points

2nd Resistance Point 109.22
1st Resistance Point 108.41
Last Price 107.60
1st Support Level 106.93
2nd Support Level 106.26

See More

52-Week High 149.34
Fibonacci 61.8% 129.03
Fibonacci 50% 122.76
Fibonacci 38.2% 116.49
Last Price 107.60
52-Week Low 96.18

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart